Evidence map›Paper›PMID 38485490›Full record

Observational studyBMJ open2024

Association between benzodiazepine coprescription and mortality in people on opioid replacement therapy: a population-based cohort study.

Catherine Susan Best, Catriona Matheson, James Robertson, Trina Ritchie, Fiona Cowden, Josh Dumbrell, Clare Duncan, Karthigayan Kessavalou, Caroline Woolston, Joe Schofield

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04622995 (Exploring the Utility and Safety of Benzodiazepine Prescribing Among People Receiving Opiate Replacement Therapy in Scotland), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04622995 completednot on this map

Exploring the Utility and Safety of Benzodiazepine Prescribing Among People Receiving Opiate Replacement Therapy in Scotland (the BENZORT Study).

TypeobservationalSponsorUniversity of StirlingRan2021 to 2022Enrolled46,899ConditionsSubstance-Related DisordersArmsBenzodiazepine
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Catherine Susan BestFaculty of Health Sciences and Sport, University of Stirling, Stirling, UK catherine.best2@stir.ac.uk.ORCID 0000-0002-3652-2498
Catriona MathesonUniversity of Stirling, Stirling, UK.
James RobertsonMuirhouse Medical Group, Edinburgh, UK.
Trina RitchieNHS Greater Glasgow and Clyde, Glasgow, UK.ORCID 0000-0002-5409-700X
Fiona CowdenNHS Tayside, Dundee, UK.
Josh DumbrellUniversity of Stirling, Stirling, UK.
Clare DuncanNHS Ayrshire and Arran, Ayr, UK.
Karthigayan KessavalouNHS Ayrshire and Arran, Ayr, UK.
Caroline WoolstonNHS Ayrshire and Arran, Ayr, UK.
Joe SchofieldSchool of Health in Social Science, The University of Edinburgh College of Humanities and Social Science, Edinburgh, UK.ORCID 0000-0002-1307-2375

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the association between opioid replacement therapy (ORT) and benzodiazepine (BZD) coprescription and all-cause mortality compared with the prescription of ORT alone.

designPopulation-based cohort study.

settingScotland, UK.

participantsParticipants were people prescribed ORT between January 2010 and end of December 2020 aged 18 years or above.

main outcome measuresAll-cause mortality, drug-related deaths and non-drug related deaths. SECONDARY OUTCOME: ORT continuous treatment duration. ANALYSIS: Cox regression with time-varying covariates.

resultsDuring follow-up, 5776 of 46 899 participants died: 1398 while on coprescription and 4378 while on ORT only. The mortality per 100 person years was 3.11 during coprescription and 2.34 on ORT only. The adjusted HR for all-cause mortality was 1.17 (1.10 to 1.24). The adjusted HR for drug-related death was 1.14 (95% CI, 1.04 to 1.24) and the hazard for death not classified as drug-related was 1.19 (95% CI, 1.09 to 1.30).

conclusionCoprescription of BZDs in ORT was associated with an increased risk of all-cause mortality, although with a small effect size than the international literature. Coprescribing was also associated with longer retention in treatment. Risk from BZD coprescription needs to be balanced against the risk from illicit BZDs and unplanned treatment discontinuation. A randomised controlled trial is urgently needed to provide a clear clinical direction. TRIAL REGISTRATION NUMBER: NCT04622995.

Indexed as

BenzodiazepinesOpiate Substitution TreatmentAdultAnalgesics, OpioidCohort StudiesEuropean PeopleHumansRetrospective StudiesScotlandAnalgesics, OpioidBenzodiazepinesCLINICAL PHARMACOLOGYEPIDEMIOLOGYSubstance misuse

Identifiers

PMID38485490
PMCPMC10941108

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.